Drugs / Folic/folinic acid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02379091 Background | Dec 2014 → May 2016 | rheumatoid arthritis | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Folic/folinic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02379091 ↗ |
| Route | Oral | “methotrexate tablets (15-25 mg weekly) and folic acid (at least 5 mg/week) orally throughout the duration of the study” NCT02379091 ↗ |